Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03002974 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Acute Gouty Arthritis
A Phase 2 study, sponsored by Swedish Orphan Biovitrum.
- Completed
- Registry status
- Phase 2
- Development phase
- 165
- Enrollment target
NCT03002974: Completed Phase 2 study, sponsored by Swedish Orphan Biovitrum.
NCT03002974 is a Phase 2 study that has completed, run by Swedish Orphan Biovitrum. The registered enrollment target is 165 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (24% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03002974, a Phase 2 study, has completed, sponsored by Swedish Orphan Biovitrum.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 165 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate how anakinra relieves pain for patients with acute gout that cannot take non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine. The patients will be divided in different treatment groups to compare anakinra to the available drug triamcinolone.
Primary Outcome
Patients will score their pain intensity in the joint most affected at baseline (index joint) on a 0-100 mm visual analogue scale (VAS), ranging from no pain (0) to unbearable pain (100). Average of the assessments performed at 24, 48 and 72 hours.
Interventions
- DRUG Anakinra 100 mg
- DRUG Triamcinolone Acetonide 40 mg
- DRUG Placebo to Anakinra 100 mg
- DRUG Placebo to Triamcinolone Acetonide 40 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2016-12 |
| Est. Completion | 2019-08 |
| Phase | Phase 2 |
What the finished NCT03002974 record still lists
NCT03002974 is an interventional study that assigns participants to a tested intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (24% higher).
The record links to 0 conditions, and to 4 interventions - of which Anakinra 100 mg is the first listed.
NCT03002974 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03002974 about?
NCT03002974 is a clinical study titled "A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Acute Gouty Arthritis". The purpose of this study is to evaluate how anakinra relieves pain for patients with acute gout that cannot take non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine. The patients will be divided in different treatment groups to compare anakinra to the available drug triamcinolone.
What is the current status of trial NCT03002974?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 165 participants. The study started on 2016-12. Estimated completion is 2019-08.
What interventions are being tested in trial NCT03002974?
The interventions under investigation include: Anakinra 100 mg (DRUG), Triamcinolone Acetonide 40 mg (DRUG), Placebo to Anakinra 100 mg (DRUG), Placebo to Triamcinolone Acetonide 40 mg (DRUG).
Who is sponsoring clinical trial NCT03002974?
This trial is sponsored by Swedish Orphan Biovitrum, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03002974's enrollment target sits among peer trials
165 410th of 2000 higher than 1,588 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02387255 · 165 participants
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms
- NCT03351348 · 165 participants · Phase 3
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
- NCT03830320 · 165 participants · Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
- NCT04289571 · 165 participants · Phase 1
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia